Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) is a clinical research site located in San Francisco, California, United States 94143-2202.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis.
Sponsors: argenx.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) has 1 clinical trials on record, with 1 currently active. Their work covers Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis.
Amyotrophic Lateral Sclerosis (ALS) Treatment Center,University of California San Francisco (UCSF) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.